Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Citrine Global Corp (CTGL)

Citrine Global Corp (CTGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 626
  • Shares Outstanding, K 1,044,074
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,650 K
  • 60-Month Beta 0.35
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CTGL with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $0.00 on 11/20/23
  • Next Earnings Date 08/15/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0003 +100.00%
on 07/12/24
0.0115 -94.78%
on 06/18/24
-0.0144 (-96.00%)
since 06/11/24
3-Month
0.0003 +100.00%
on 07/12/24
0.0150 -96.00%
on 06/11/24
-0.0119 (-95.20%)
since 04/15/24
52-Week
0.0003 +100.00%
on 07/12/24
0.0380 -98.42%
on 07/18/23
-0.0371 (-98.41%)
since 07/14/23

Most Recent Stories

More News
Citrine Global Corp. (OTCQB: CTGL) Announced its Subsidiary Files Provisional Patent Application Targeting to Address Oral Cavity Side Effects Associated with the Use of Medicines, Treatments, Aging or an Unbalanced/Unhealthy Lifestyle

Tel Aviv, July 18, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that the Company’s subsidiary, Cannovation Center...

CTGL : 0.0006 (-86.96%)
Citrine Global Corp. (OTCQB: CTGL) Announces Prof. Itamar Grotto, a World-Renowned Expert in Public Health, Joining the Company’s Israeli Subsidiary Board of Directors, and Appointed as President of Green Vision Center Israel

Prof. Grotto is a world-renowned expert in public health; formerly Associate Director General and Director of the Public Health Services of the Israeli...

CTGL : 0.0006 (-86.96%)
Citrine Global CEO Issues Letter to Shareholders

Tel Aviv, April 13, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL), a plant-based wellness and pharma solutions company, today issued a...

CTGL : 0.0006 (-86.96%)
Citrine Global Subsidiary Acquires 11,687 sqm of Industrial Land to Build its 5,500 sqm “Green Vision Center”

Green Vision Center is a unique platform of a production and innovation center focused on botanical solutions such as medicinal herbal plants, medical...

CTGL : 0.0006 (-86.96%)
Citrine Global Corp.’s (OTCQB: CTGL) Subsidiary, Cannovation Center Israel Ltd., is Pleased to Announce the Launch of its "Green Side by Side" Products Line and the Signing of an Agreement with Intelicanna to Sell the Products in Israel

Tel Aviv, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp.’s (OTCQB: CTGL) subsidiary, Cannovation Center Israel Ltd. (Cannovation), announced that...

CTGL : 0.0006 (-86.96%)
Citrine Global Subsidiary Files in the U.S. Patent & Trademark Office a Provisional Patent Application for “PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF SIDE EFFECTS ASSOCIATED WITH THE USE OF CANNABIS & RELATED PRODUCTS”

Tel Aviv, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Citrine Global, Corp. (OTCQB: CTGL) is pleased to announce that its subsidiary, Cannovation Center Israel...

CTGL : 0.0006 (-86.96%)
Citrine Global Subsidiary Enters into Manufacturing Agreement for the Green Botanicals Product Line

Tel Aviv, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Citrine Global, Corp. (OTCQB: CTGL) is pleased to announce that its subsidiary, Cannovation Center Israel Ltd., has entered into a manufacturing agreement...

CTGL : 0.0006 (-86.96%)
Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Directors

HAIFA, Israel, July 19, 2021 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading biotechnology company, today announced the Board of Director appointments...

HMD.AX : 0.023 (unch)
PSTI : 1.0000 (-2.91%)
INTL : 22.81 (-1.01%)
ICCM : 0.7464 (-0.48%)
CTGL : 0.0006 (-86.96%)
Mr. Hagai Hillman Joins Cannovation Center Israel Ltd. as a CEO Bringing with Him Decades of Experience and Proven Track Record in the Pharma, Botanical and Medical Cannabis Industries

Tel Aviv, May 05, 2021 (GLOBE NEWSWIRE) -- Citrine Global, Corp. (OTCQB: CTGL) (“Citrine Global”) is pleased to announce that Mr. Hagai Hillman has been appointed as a chief executive officer of...

CTGL : 0.0006 (-86.96%)
Citrine Global, Corp. (OTCQB: CTGL) announces that the loan provided to Intelicanna Ltd. (TASE: INTL) in July 2020 under the loan agreement entered between the parties, has been repaid.

Tel-Aviv, April 05, 2021 (GLOBE NEWSWIRE) -- Citrine Global, Corp. (OTCQB: CTGL) (“Citrine Global”) is pleased to update that on March 31, 2021 the loan of NIS 500 thousand extended to Intelicanna...

CTGL : 0.0006 (-86.96%)
INTL : 22.81 (-1.01%)

Business Summary

Citrine Global Corp. is a plant-based wellness & pharma solutions company. Its business activity is primarily comprised of developing wellness and pharma solutions. Citrine Global Corp. is based in Tel Aviv.

See More

Key Turning Points

3rd Resistance Point 0.0006
2nd Resistance Point 0.0006
1st Resistance Point 0.0006
Last Price 0.0006
1st Support Level 0.0006
2nd Support Level 0.0006
3rd Support Level 0.0006

See More

52-Week High 0.0380
Fibonacci 61.8% 0.0236
Fibonacci 50% 0.0192
Fibonacci 38.2% 0.0147
Last Price 0.0006
52-Week Low 0.0003

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar